Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node-positive bladder cancer: Results of a prospective study

被引：0
|
作者：
Lyu, Q. [1 ]
Yang, X. [1 ]
Cao, Q. [1 ]
Zhuang, J. [1 ]
机构：
[1] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Peoples R China
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0904
引用
收藏
页码：S1957 / S1957
页数：1
相关论文
共 50 条
  • [1] Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node-positive bladder cancer: Results of a prospective study.
    Yang, Xiao
    Zhuang, Juntao
    Cao, Qiang
    Cai, Lingkai
    Wu, Qikai
    Lu, Qiang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 619 - 619
  • [2] Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node-positive bladder cancer
    Yang, Xiao
    Cao, Qiang
    Li, Pengchao
    Cai, Lingkai
    Zhuang, Juntao
    Lyu, Qiang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Xing, N.
    Han, S.
    Jiang, J.
    Xu, W.
    Shi, B.
    Ping, H.
    Ji, Z.
    Ma, Q.
    Wang, H.
    Chen, S.
    Wang, W.
    Fan, X.
    Zhou, Q.
    Zhang, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S714 - S714
  • [4] Bladder Cancer - Neoadjuvant Therapy with Cisplatin and Gemcitabine
    Schmid, Sebastian C.
    Gschwend, Juergen E.
    Retz, Margitta
    AKTUELLE UROLOGIE, 2013, 44 (05) : 340 - 342
  • [5] Lymph node-positive prostate cancer: Evaluation of the results of the combination of androgen deprivation therapy and radiation therapy
    Buskirk, SJ
    Pisansky, TM
    Atkinson, EJ
    Schild, SE
    O'Brien, PC
    Wolfe, JT
    Zincke, H
    MAYO CLINIC PROCEEDINGS, 2001, 76 (07) : 702 - 706
  • [6] Selective Extirpation of Tattooed Lymph Node in Combination with Sentinel Lymph Node Biopsy in the Management of Node-Positive Breast Cancer Patients after Neoadjuvant Systemic Therapy
    Dostalek, Lukas
    Cerny, Andrej
    Saskova, Petra
    Pavlista, David
    BREAST CARE, 2021, 16 (06) : 623 - 629
  • [7] THE VALUE OF NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE-POSITIVE BLADDER CANCER
    Werntz, Ryan
    Smith, Zach
    Packiam, Vignesh
    Riedinger, Chris
    Fantus, Jake
    Smith, Norm
    Steinberg, Gary
    JOURNAL OF UROLOGY, 2018, 199 (04): : E314 - E315
  • [8] Outcomes of Patients with Clinical Lymph Node-Positive Bladder Cancer after Neoadjuvant Chemotherapy, Radical Cystectomy, and Lymph Node Dissection
    Yamashita, R.
    Seiler, R.
    Zehnder, P.
    Burkhard, F.
    Thalmann, G.
    UROLOGY, 2012, 80 (03) : S211 - S211
  • [9] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [10] Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer
    Nieuwenhuijzen, JA
    Bex, A
    Meinhardt, W
    Kerst, JM
    Schornagel, JH
    Van Tinteren, H
    Horenblas, S
    JOURNAL OF UROLOGY, 2005, 174 (01): : 80 - 84
12345